No immediate trading signal; monitor for future Form 4 filings that may indicate actual option exercises or share transactions. Fully vested options could lead to future selling or exercising depending on stock price performance.
Price Chart
Executive Summary
Alexander Zukiwski, Global Chief Medical Officer of CASI Pharmaceuticals, filed a Form 3 disclosing ownership of stock options to purchase 146,333 ordinary shares at $1.93 per share, all of which are fully vested as of March 18, 2026. This is a routine initial filing for insider ownership and does not indicate new transactions or material changes in company fundamentals.
Key Facts
- Reporting person: Alexander Zukiwski, Global Chief Medical Officer
- Form 3 filed on April 3, 2026, covering ownership as of March 18, 2026
- Options to purchase 146,333 ordinary shares at $1.93 per share
- All options are fully vested and exercisable
- No shares directly owned; only options reported
Financial Impact
Options cover 146,333 shares at $1.93 strike price; no immediate financial impact as no exercise or transaction occurred
Risk Factors
- Potential for future insider selling if stock price rises above strike price
- Limited liquidity risk given small option size relative to typical biotech float
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001104659-26-039647 |
| Document: 0001104659-26-039647-index.html | 0001104659-26-039647 |
| Document: 0001104659-26-039647.txt | 0001104659-26-039647 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 2, 2026 7w ago | 6-K | $0.1400 | awaiting T+60 | — | $0.1000 (−28.57%) |
Aug 14, 2026 10w ago | 6-K | $0.1500 | awaiting T+60 | — | $0.1000 (+33.33%) |
Jul 15, 2026 14w ago | 6-K | $0.1400 $0.1100 | ▼ −21.43% | ▼ −24.22% | $0.1000 (−28.57%) |
Jun 29, 2026 17w ago | 6-K | $0.1200 $0.1300 | ▲ +8.33% | ▲ +5.29% | $0.1000 (−16.67%) |
Jun 2, 2026 21w ago | 6-K | $0.1100 $0.1300 | ▲ +18.18% | ▲ +17.06% | $0.1000 (−9.09%) |
Apr 23, 2026 26w ago | 3 | $0.1300 $0.1700 | ▲ +30.77% | ▲ +25.75% | $0.1000 (−23.08%) |
Apr 20, 2026 27w ago | 6-K | $0.1700 $0.1344 | ▼ −20.94% | ▼ −27.84% | $0.1000 (−41.18%) |
Apr 20, 2026 27w ago | 6-K | $0.1700 $0.1250 | ▲ +26.47% | ▲ +33.25% | $0.1000 (+41.18%) |
Apr 15, 2026 27w ago | 6-K | $0.1500 $0.1451 | ▼ −3.27% | ▼ −11.40% | $0.1000 (−33.33%) |
Apr 3, 2026 29w ago | 3 | $0.1400 $0.2400 | ▲ +71.43% | ▲ +57.96% | $0.1000 (−28.57%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers